NOT AVAILABLE
Report
- Report Number
- 9611165-2014-00078
- Event Type
- Other
- Date Received
- November 11, 2014
- Report Date
- October 31, 2014
- Manufacturer
- RAYNER INTRAOCULAR LENSES LTD.
- Product Code
- HQL
- PMA / PMN Number
- P060011
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- UK
- Reporter Occupation
- PHYSICIAN
Narratives
THE REFERENCE (B)(4) HAS BEEN ALLOCATED TO THIS CASE BY RAYNER. AT THIS TIME, NO INFORMATION OTHER THAN THAT PROVIDED HAS BEEN MADE AVAILABLE TO RAYNER. RAYNER IS LIAISING WITH THE HEALTHCARE FACILITY TO OBTAIN ADDITIONAL INFORMATION TO AID US IN THE INVESTIGATION OF THE REPORTED DEVELOPMENT OF IOL OPACIFICATION. IOL OPACIFICATION IS SAID TO HAVE BEEN OBSERVED POST DSAEK SURGERY. RAYNER IS CURRENTLY WORKING TO ASCERTAIN WHAT SUBSTANCES MAY HAVE COME INTO CONTACT WITH THE IOL DURING THIS PROCEDURE. THE PATIENT'S MEDICAL HISTORY HAS ALSO BEEN REQUESTED AS IT HAS BEEN REPORTED WITHIN LITERATURE THAT PATIENT'S WITH DIABETES ARE MORE PRE-DISPOSED TO CALCIUM BUILD UP AND BREAK DOWN OF THE NORMAL BLOOD-AQUEOUS BARRIER. ANY FOLLOW-UP INFORMATION RECEIVED WILL BE PROVIDED IN A FOLLOW-UP REPORT. THE EXPLANTED IOL WILL BE RETURNED TO RAYNER FOR ANALYSIS. ANALYSIS OF THE IOL WILL BE UNDERTAKEN BY A THIRD PARTY INDEPENDENT LABORATORY. THE IOL WILL UNDERGO STRUCTURAL AND ULTRASTRUCTURAL ANALYSIS (ALIZARIN RED STAINING, LIGHT MICROSCOPY, SCANNING ELECTRON MICROSCOPY AND ENERGY DISPERSIVE X-RAY FLUORESCENCE SPECTROSCOPY (EDX)). THE RESULTS OF THE DEVICE ANALYSIS WILL BE PROVIDED IN A FOLLOW-UP REPORT.
RAYNER INTRAOCULAR LENSES LIMITED RECEIVED NOTIFICATION OF AN EVENT THAT OCCURRED FOLLOWING IMPLANTATION OF AN UNSPECIFIED RAYNER IOL. THE HEALTHCARE PROFESSIONAL REPORTS THAT OPACIFICATION OF THE IOL WAS DETECTED POST DSEK SURGERY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 726438 | NOT AVAILABLE | HQL - INTRAOCULAR LENS | HQL | RAYNER INTRAOCULAR LENSES LTD. | NA | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |